Abstract:Vascular endothelial growth factor (VEGF) has been found responsible for the induction of proliferation and differentiation in granulosa cells. We constructed four short hairpin RNA (shRNA) expression plasmids targeting the mouse VEGFA gene, and examined their effect on VEGF expression in mouse granulosa cells (MGC) in vitro. Four different shRNA oligonucleotides targeting the coding sequence of mouse VEGFA mRNA and one negative control (shNC) were designed and cloned into a pGPU6/GFP/Neo siRNA expression vector, and transiently transfected into MGC. At 48 h post-transfection, total RNA was extracted from the cells and subjected to qRT-PCR analysis. The most effective interference vector, shVEGF1487 was chosen for lentiviral construction. The recombinant plasmid was then transfected into 293FT cells via Lipofectamine(TM) 2000-mediated gene transfer, for the production of lentivirus, and then concentrated via ultracentrifugation. This lentiviral vector was then used for the transduction of MGC. VEGFA gene expression, apoptosis genes and VEGFA receptor genes were detected by qRT-PCR, the VEGFA protein level in culture media by ELISA assay and protein levels in MGC by Western blot analysis. The four VEGFA expression plasmids were successfully constructed and the most effective interference vector, shVEGF1487, was chosen for lentiviral production and MGC transduction. There was significant knockdown of the VEGFA gene, receptor genes and apoptosis genes for all the shVEGF constructs, compared with the shNC and Mock controls. The lentiviral vector also gave significant knockdown of the VEGFA gene. Protein levels were lower for most of the shVEGFs based on Western blot analysis with exception of VEGF1359; in this case, it was higher than shNC but lower than for the Mock group. Lentivector-transduced MGC also gave lower levels of protein. We conclude that shVEGF expression plasmids and lentivector carrying RNAi are promising tools for the inhibition of VEGF, the corresponding receptor genes, and apoptosis gene expression in MGC.

In Vitro Inhibition of Lipoprotein Lipase Gene Expression by RNA Interference

Efficient Inhibition of Human Cytomegalovirus DNA Polymerase Expression by Small Hairpin RNA in Vitro

Inhibition of HBV Core Antigen Gene Expression in Human Embryonic Kidney Cell Line AD293 by Plasmid-Based RNAi

Construction and Functional Analysis of Short Interfering RNA Expression Vectors of Targeting Gene Apolipoprotein M

Recent updates on therapeutic targeting of lipoprotein(a) with RNA interference

Lentiviral-mediated RNA Interference of Lipoprotein-Associated Phospholipase A2 Ameliorates Inflammation and Atherosclerosis in Apolipoprotein E-deficient Mice

Antisense microRNA185 loaded liposome for efficient inhibition of the hepatic endogenous microRNA185 level

Construction of the recombinant adenovirus mediated short hairpin RNA to silence Polo-like kinase 1 and its biomedical application

Thermostable ionizable lipid-like nanoparticle (iLAND) for RNAi treatment of hyperlipidemia

Knockdown of Apolipoprotein B, an Atherogenic Apolipoprotein, in HepG2 Cells by Lentivirus-Mediated Sirna

Targeting ANGPTL3 by GalNAc-conjugated Sirna ANGsiR10 Lowers Blood Lipids with Long-Lasting and Potent Efficacy in Mice and Monkeys.

Construction of Small Hair RNA Lentiviral Vectors Targeting PCSK9 Gene and Its Silent Effects on PCSK9 Gene

Inhibition of Hepatitis B Virus Surface Antigen Expression by Small Hairpin RNAin Vitro

Inhibition of Vascular Endothelial Growth Factor A Expression in Mouse Granulosa Cells by Lentivector-Mediated RNAi.

Three New Shrna Expression Vectors Targeting the CYP3A4 Coding Sequence to Inhibit Its Expression

In Vivo Endothelial Cell Gene Silencing by siRNA‐LNPs Tuned with Lipoamino Bundle Chemical and Ligand Targeting

[Inhibition of VEGF Expression by Plasmid-Based RNA Interference in the Retinoblastoma Cells].

shRNA Transcribed by RNA Pol II Promoter Induce RNA Interference in Mammalian Cell

Down-regulation of lactate dehydrogenase-A by siRNAs for reduced lactic acid formation of Chinese hamster ovary cells producing thrombopoietin

Advances in lipid-lowering therapy through gene-silencing technologies

Inhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated siRNA delivery